2016
DOI: 10.1002/ange.201607831
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3

Abstract: The chemokine receptor CXCR3 is a G protein‐coupled receptor that conveys extracellular signals into cells by changing its conformation upon ligand binding. We previously hypothesized that small‐molecule allosteric CXCR3‐agonists do not bind to the same allosteric binding pocket as 8‐azaquinazolinone‐based negative allosteric modulators. We have now performed molecular‐dynamics (MD) simulations with metadynamics enhanced sampling on the CXCR3 system to refine structures and binding modes and to predict the CXC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…Recent simulations on a variety of GPCRs have shown that the extracellular vestibule of the receptor can preorient the ligand 34−39 and thus provide a well-defined extracellular end point for docking pathways, thereby simplifying the pathsampling task, often by a form of electrostatic focusing 40 but also by a simple mechanical effect in which part of the ligand is anchored, decreasing the number of degrees of freedom to be sampled. This property of the extracellular region renders our simple CV quite effective; only a few pathways for GPCR− ligand binding are possible, the ligands find the right orientation during the sampling, and binding sites along the path are identified and characterized reliably.…”
Section: Variablementioning
confidence: 99%
See 1 more Smart Citation
“…Recent simulations on a variety of GPCRs have shown that the extracellular vestibule of the receptor can preorient the ligand 34−39 and thus provide a well-defined extracellular end point for docking pathways, thereby simplifying the pathsampling task, often by a form of electrostatic focusing 40 but also by a simple mechanical effect in which part of the ligand is anchored, decreasing the number of degrees of freedom to be sampled. This property of the extracellular region renders our simple CV quite effective; only a few pathways for GPCR− ligand binding are possible, the ligands find the right orientation during the sampling, and binding sites along the path are identified and characterized reliably.…”
Section: Variablementioning
confidence: 99%
“…A preliminary metadynamics simulation is used to refine the poses and determine the one with the highest binding free energy, as described previously. 40 The ligand is first unbound using a faster protocol (see Methods for details). The position on the reaction coordinate at which the ligand is completely hydrated and unbound is determined, and representative structures are extracted from the simulation for each 2 Å window along the reaction coordinate from the docked pose to the unbound state.…”
Section: ■ Computational Protocolmentioning
confidence: 99%
“…By using the multiple walker approach, which introduces several simultaneous simulations with shared potentials, metadynamics gets even more efficient. To date, metadynamics simulations have been successfully used to study GPCR-ligand interactions in a couple of cases including opioid [ 18 , 19 ], vasopressin [ 20 ], chemokine [ 21 ], or cannabinoid receptors [ 22 ].…”
Section: Introductionmentioning
confidence: 99%